CAR T‐Cell Therapy in Neurology: A Scoping Review of Neuro‐Oncology, Autoimmune Diseases & Neurotoxicity
Annals of Clinical and Translational Neurology · 2026-07 · 13 (7) · 1310-1319
DOI: 10.1002/acn3.70415 ↗Kurz gefasst
Scoping Review in der Zeitschrift Annals of Clinical and Translational Neurology, online erschienen am 27.04.2026. Verfasst von Omar Alqaisi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Nursing Department, Al-Zaytoonah University, Amman, Jordan. Hauptthemen laut MEDLINE: Autoimmune Diseases, Immunotherapy, Adoptive, Nervous System Diseases, Neurology. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Chimeric antigen receptor (CAR) T‐cell therapy has been investigated in neurological diseases, encompassing both central nervous system malignancies and autoimmune disorders, thereby extending its application beyond hematological cancers. This scoping review evaluates CAR T‐cell therapy applications in neurological conditions, assessing therapeutic efficacy, safety profiles, and neurotoxicity management strategies. A literature search across four databases (January 2020–December 2025) identified 33 studies meeting the inclusion criteria, encompassing original and secondary research from international centers. CAR T‐cell therapy demonstrated promising efficacy across diverse neurological conditions. In glioblastoma trials, 44% of patients ( n = 128) achieved partial or complete clinical/radiographic responses with favorable safety profiles. Moreover, compelling results emerged from neuromyelitis optica spectrum disorder studies, in which 92% of patients (11/12) achieved sustained relapse‐free remission over a median follow‐up of 5.5 months. Multiple sclerosis, myasthenia gravis, and stiff‐person syndrome cases exhibited excellent treatment tolerance without significant immune effector cell‐associated neurotoxicity syndrome (ICANS), which is a major concern affecting 27% of patients with hematological malignancies. Overall, CAR T‐cell therapy emerges as a novel therapeutic strategy in neurology, encompassing both oncological and autoimmune conditions. Toxicity profiles in neurological CAR T‐cell applications differ substantially from those observed in hematologic malignancies, underscoring the need for condition‐specific risk assessment frameworks and customized management approaches. Future research should prioritize larger multicenter trials with extended follow‐up to establish definitive efficacy and safety profiles in neurological indications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nursing Department, Al-Zaytoonah University, Amman, Jordan.
- Department of Medicine, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine.
- Department of Oncology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
- Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
ORCID-Profile: Omar Alqaisi, Mohammed Dibas, Patricia Tai, Ala Dibas, Osama Souied, Suhair Al-Ghabeesh
Zitieren
APA
Alqaisi, O., Dibas, M., Tai, P., Dibas, A., Souied, O., & Al-Ghabeesh, S. (2026). CAR T‐Cell Therapy in Neurology: A Scoping Review of Neuro‐Oncology, Autoimmune Diseases & Neurotoxicity. Annals of Clinical and Translational Neurology, 13(7), 1310-1319. https://doi.org/10.1002/acn3.70415
Vancouver
Alqaisi O, Dibas M, Tai P, Dibas A, Souied O, Al-Ghabeesh S. CAR T‐Cell Therapy in Neurology: A Scoping Review of Neuro‐Oncology, Autoimmune Diseases & Neurotoxicity. Annals of Clinical and Translational Neurology. 2026;13(7):1310-1319. doi:10.1002/acn3.70415
BibTeX
@article{Alqaisi2026,
author = {Alqaisi, Omar and Dibas, Mohammed and Tai, Patricia and Dibas, Ala and Souied, Osama and Al-Ghabeesh, Suhair},
title = {CAR T‐Cell Therapy in Neurology: A Scoping Review of Neuro‐Oncology, Autoimmune Diseases & Neurotoxicity},
journal = {Annals of Clinical and Translational Neurology},
year = {2026},
volume = {13},
number = {7},
pages = {1310--1319},
doi = {10.1002/acn3.70415}
}
EUVIMED